Clinical trial
The Neurobiological Effect of 5-HT2AR Modulation
NCT03289949 is registered in ClinicalTrials.gov with Gitte Moos Knudsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Neurobiological Effect of 5-HT2AR Modulation
- Lead sponsor
- Gitte Moos Knudsen
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- March 3, 2017
- Completion date
- June 1, 2030
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
basic science